{"store":{"baseInfo":{"podcastTitle":"The RWD & RWE Podcast","slug":"RWDRWE","podcastDescription":"*** Join our weekly Real-World Wednesdays (RWW) Clubhouse room every Wed @ 11am Eastern US Time***\n\nAll things related to the collection, creation & use of Real-World Data (RWD) in generating Real-World Evidence (RWE) for clinical research, drug development, medical devices, value access and other activities for BioPharma and the Life Sciences!\n\nReal-World Data (RWD): data relating to a person’s health status or well-being, or the care received by a person, as collected from real-world settings (as opposed to the controlled clinical trial setting) [aka observational data, healthcare data, etc.]\n\nReal-World Evidence (RWE): the appropriate analysis of RWD\n\nReliable RWD + Appropriate Analysis = Meaningful RWE","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi.jpeg","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_1200x628.jpg?s=c5a79c556d88f0f2287ef8cd3e99f879&e=jpeg","podcastUrl":"https://RWDRWE.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/RWDRWE/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pu/pbblog-ji9m3-cda90a","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":9,"gmtAdjustment":"GMT-07:00","useDaylightTime":1,"value":-7,"text":"(GMT-07:00) Mountain Time (US & Canada)","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":"America/Denver"},"podcastDownloads":null,"totalEpisodes":141,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"Aaron Kamauu & Matt Veatch","engagementStatsBaseUrl":"https://d1.podbean.com/webplayer_engagement?u=680363a8501283f8f30ae7e3","shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-ji9m3-cda90a-playlist","language":"en","sensitivitySessionExpireTime":86400,"podcastApps":[{"name":"Apple Podcasts","link":"https://podcasts.apple.com/us/podcast/the-rwd-rwe-podcast/id1629929529","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/apple-podcast.png","title":null},{"name":"Podbean App","link":"https://r4j68.app.goo.gl/?link=https%3A%2F%2FRWDRWE.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog13478154%26podcastIdTag%3Dji9m3&dfl=https%3A%2F%2FRWDRWE.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null},{"name":"Spotify","link":"https://open.spotify.com/show/7lUgddzKtRvQ88AaUdCiEv","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/spotify.png","title":null},{"name":"Amazon Music","link":"https://music.amazon.com/podcasts/e367356a-0346-4ea8-a172-62eb746ca4ce","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/AmazonMusic.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"grid"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/6v9AYdIzDun3","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-nMojxgh8wTwV","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2022 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":true,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://rwdrwe.podbean.com","apiCommonParams":{"t":"680363a8","clientSignature":"12acd6d4a0782f6a3c531792fb667bd7","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb20019208-qvbae","episode":{"id":"pb20019208","idTag":"qvbae","title":"16 November 2022: Matt Zierhut PhD MS MBA – The ”secondary use” of clinical trial data to support RWE","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_300x300.jpeg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_1200x628.jpg?s=c5a79c556d88f0f2287ef8cd3e99f879&e=jpeg","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi.jpeg","previewContent":null,"content":"

16 November 2022: Conversation with Matt Zierhut PhD MS MBA, VP Integrated Drug Development at Certara – We discussed the value of clinical trial data outside its initial purpose, that is, the secondary use of trial data to support RWE.

","publishTimestamp":1668633075,"duration":3650,"mediaUrl":"https://mcdn.podbean.com/mf/web/b3mq7m/2022-11-16-Matt_Zierhut_edited.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-qvbae-1317808","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-qvbae-1317808","transcriptUrl":null,"permalink":"/e/16-november-2022-matt-zierhut-phd-ms-mba-%e2%80%93-the-secondary-use-of-clinical-trial-data-to-support-rwe/","downloadLink":"https://www.podbean.com/site/EpisodeDownload/PB1317808QVBAE","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":125,"status":"publish","hasMoreContent":false,"chaptersUrl":null,"explicit":false},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-qvbae-1317808","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false},"episode":{"id":"pb20019208","idTag":"qvbae","title":"16 November 2022: Matt Zierhut PhD MS MBA – The ”secondary use” of clinical trial data to support RWE","logo":"https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_300x300.jpeg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi_1200x628.jpg?s=c5a79c556d88f0f2287ef8cd3e99f879&e=jpeg","largeLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/13478154/5461863D-DD50-4985-A9DB-1CF441B320EE_nbtefi.jpeg","previewContent":null,"content":"

16 November 2022: Matt Zierhut PhD MS MBA – The ”secondary use” of clinical trial data to support RWE

Comments (0)